Whitney R. Buckel

1.0k citations

34 papers · 683 indexed · h-index 15

Infectious Diseases top 5%
Applied Microbiology and Biotechnology top 0.5%
Epidemiology
General Health Professions top 10%
Neurology top 10%

Co-authors: Edward Stenehjem Brandon Webb Rajendu Srivastava Ithan D. Peltan Adam L. Hersh Samuel M. Brown Nathan Starr Nancy Grisel
Topics: Antibiotic Use and Resistance (17 papers)Patient Satisfaction in Healthcare (13 papers)COVID-19 Clinical Research Studies (6 papers)
Cited by: Applied Microbiology and Biotechnology Infectious Diseases Clinical Biochemistry
Journals: SHILAP Revista de lepidopterologíaClinical Infectious Diseases CHEST Journal
Partner nations: United States New Zealand

In The Last Decade

Whitney R. Buckel

31 papers receiving 673 citations

Peers

Countries citing papers authored by Whitney R. Buckel

Since Specialization

Citations

This map shows the geographic impact of Whitney R. Buckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney R. Buckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney R. Buckel more than expected).

Fields of papers citing papers by Whitney R. Buckel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whitney R. Buckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney R. Buckel. The network helps show where Whitney R. Buckel may publish in the future.

Co-authorship network of co-authors of Whitney R. Buckel

This figure shows the co-authorship network connecting the top 25 collaborators of Whitney R. Buckel. A scholar is included among the top collaborators of Whitney R. Buckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whitney R. Buckel. Whitney R. Buckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection 2025 ·Clinical Infectious Diseases ·Rebekah W. Moehring,(unknown),Elizabeth Dodds Ashley,Rachel Addison,Whitney R. Buckel,Sara E. Cosgrove,(unknown),Eili Klein,Carlos A.Q. Santos,Emily S Spivak,William E. Trick,Michael J. Smith,David J. Weber,Congwen Zhao,Deverick J. Anderson,Benjamin A. Goldstein	0
2	Interventions to optimize duration of antibiotic therapy and encourage oral transition for uncomplicated gram-negative blood stream infections across a health system 2025 ·Infection Control and Hospital Epidemiology ·Jared Olson,Adam L. Hersh,(unknown),C. Dustin Waters,Brandon Webb,(unknown),(unknown),(unknown),Nora F. Fino,Rachel Foster,(unknown),Erin D. Stahl,James B. Rhodes,Edward Stenehjem,Andrew T. Pavia,Payal Patel,Allan Seibert,Whitney R. Buckel	0
3	Clinician Management Preferences for Clostridioides difficile Infection in Adults: A 2024 Emerging Infections Network Survey 2025 ·Open Forum Infectious Diseases ·(unknown),Payal Patel,Susan E. Beekmann,Philip M. Polgreen,Whitney R. Buckel,Monica V. Mahoney,Preeti Mehrotra,(unknown)	0
4	Antibiotic prescribing for adults with group A streptococcal bacteremia in a large healthcare system 2023 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Whitney R. Buckel	3
5	Beyond antibiotic prescribing rates: first-line antibiotic selection, prescription duration, and associated factors for respiratory encounters in urgent care 2023 ·SHILAP Revista de lepidopterología ·Allan Seibert,(unknown),Whitney R. Buckel,Payal Patel,Nora F. Fino,(unknown),Adam L. Hersh,Edward Stenehjem	1
6	Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source 2023 ·Open Forum Infectious Diseases ·(unknown),(unknown),(unknown),Jared Olson,(unknown),C. Dustin Waters,Allison Butler,(unknown),Whitney R. Buckel,Brandon Webb	4
7	Implementation of an Antibiotic Stewardship Initiative in a Large Urgent Care Network 2023 ·JAMA Network Open ·Edward Stenehjem,(unknown),Park W. Willis,(unknown),Allan Seibert,Whitney R. Buckel,(unknown),Kimberly D. Brunisholz,Nora F. Fino,Matthew H. Samore,Rajendu Srivastava,Lauri A. Hicks,Adam L. Hersh	21
8	Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19 2021 ·Open Forum Infectious Diseases ·Brandon Webb,Whitney R. Buckel,Todd J. Vento,Allison Butler,Nancy Grisel,Samuel M. Brown,Ithan D. Peltan,Emily S Spivak,(unknown),(unknown),(unknown),Edward Stenehjem,(unknown),Joseph Bledsoe	36
9	Interventions to optimize antimicrobial stewardship 2021 ·SHILAP Revista de lepidopterología ·(unknown),Rachel Foster,Brandon Webb,(unknown),Whitney R. Buckel,Edward Stenehjem	16
10	Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial 2020 ·Annals of the American Thoracic Society ·Samuel M. Brown,Ithan D. Peltan,(unknown),Lindsay Leither,Brandon Webb,Nathan Starr,Colin K. Grissom,Whitney R. Buckel,Rajendu Srivastava,Allison Butler,Danielle Groat,Benjamin Haaland,Ying Jian,Estelle S. Harris,Stacy A. Johnson,Robert Paine,Tom Greene	20
11	Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial 2020 ·Annals of the American Thoracic Society ·Samuel M. Brown,Ithan D. Peltan,Brandon Webb,(unknown),Nathan Starr,Colin K. Grissom,Whitney R. Buckel,Rajendu Srivastava,Estelle S. Harris,Lindsay Leither,Stacy A. Johnson,Robert Paine,Tom Greene	21
12	Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study 2020 ·The Lancet Rheumatology ·Brandon Webb,Ithan D. Peltan,Paul N. Jensen,Daanish Hoda,Bradley D. Hunter,(unknown),Nathan Starr,Whitney R. Buckel,Nancy Grisel,(unknown),Gregory L. Snow,Dave Morris,Edward Stenehjem,Rajendu Srivastava,Samuel M. Brown	214
13	Collaborative Antimicrobial Stewardship 2019 ·Infectious Disease Clinics of North America ·Whitney R. Buckel,Keith S. Kaye,Payal Patel	3
14	Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia 2019 ·CHEST Journal ·Brandon Webb,Jeffrey Sorensen,(unknown),Whitney R. Buckel,(unknown),Al Jephson,Nathan C. Dean	20
15	Antimicrobial Stewardship in Community Hospitals 2018 ·Medical Clinics of North America ·Whitney R. Buckel,(unknown),Todd J. Vento,Edward Stenehjem	31
16	Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin 2016 ·Pediatric Drugs ·Whitney R. Buckel,(unknown),Pranita D. Tamma,Aaron M. Milstone,Yuan Zhao,Alice J. Hsu	6
17	Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices 2016 ·Neurocritical Care ·(unknown),G Fontaine,(unknown),(unknown),Margaret Baldwin,Whitney R. Buckel,Dave S. Collingridge,Sarah Majercik,(unknown)	14
18	Broad- versus Narrow-Spectrum Oral Antibiotic Transition and Outcomes in Health Care–associated Pneumonia 2016 ·Annals of the American Thoracic Society ·Whitney R. Buckel,Edward Stenehjem,(unknown),Nathan C. Dean,Brandon Webb	8
19	Antibiotic Use in Small Community Hospitals 2016 ·Clinical Infectious Diseases ·Edward Stenehjem,Adam L. Hersh,Xiaoming Sheng,Peter Jones,Whitney R. Buckel,James F. Lloyd,S Howe,R. Scott Evans,Tom Greene,Andrew T. Pavia	45
20	Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing Era 2014 ·Infection Control and Hospital Epidemiology ·Whitney R. Buckel,Edina Avdic,Karen C. Carroll,Vidhya Gunaseelan,Eric Hadhazy,Sara E. Cosgrove	36

About Whitney R. Buckel

Whitney R. Buckel is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Critical Care and Intensive Care Medicine, having authored 34 papers that have together received 683 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (17 papers), Patient Satisfaction in Healthcare (13 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (256 citations), Infectious Diseases (319 citations) and Clinical Biochemistry (104 citations). Whitney R. Buckel has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Edward Stenehjem, Brandon Webb, Rajendu Srivastava, Ithan D. Peltan, Adam L. Hersh, Samuel M. Brown, Nathan Starr, Nancy Grisel, Bradley D. Hunter and Paul N. Jensen. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact